Latest article
Philly Health Week gives the town far more than simply methods to sweat
Sign up for our daily email newsletter to stay up to date with the latest local news across Philadelphia.It's time to get physical,...
Fierce Pharma Asia—AstraZeneca-Junshi PD-1 deal; Takeda’s $1.2B diabetes selloff, Ovid epilepsy collab pullout
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...